Bladder preservation: a viable alternative to radical surgery?

NCT ID NCT07744958

Not yet recruiting Knowledge-focused Sponsor: Heinrich-Heine University, Duesseldorf Source: ClinicalTrials.gov ↗

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This registry study follows bladder cancer patients who, after receiving systemic therapy, choose not to undergo bladder removal (cystectomy) or radiotherapy. The goal is to collect data on their outcomes, such as metastasis-free survival, to better understand which patients might safely preserve their bladder. By analyzing this real-world data, researchers hope to identify factors that make bladder preservation a medically sound option.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could help identify which bladder cancer patients can safely avoid bladder removal, preserving quality of life without compromising cancer control.
What could go wrong: This is an observational registry, not a controlled trial, so it cannot prove whether bladder preservation is as effective as surgery. Results may be limited by patient selection and lack of a comparison group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MUSCLE INVASIVE BLADDER CANCER (MIBC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infiltrating bladder urothelial carcinoma transitional cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MUSCLE INVASIVE BLADDER CANCER (MIBC)

More trials for these conditions

Other studies related to the condition(s) this trial covers.